Page last updated: 2024-08-23

phenyl acetate and Atherosclerotic Parkinsonism

phenyl acetate has been researched along with Atherosclerotic Parkinsonism in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ajayi, AM; Alabi, AO; Bakre, AG; Ben-Azu, B; Umukoro, S	1
Bagga, P; Chugani, AN; Patel, AB; Varadarajan, KS	1
Gruenthal, M; Mueller, ME; Olson, WH; Olson, WL	1

Trials

1 trial(s) available for phenyl acetate and Atherosclerotic Parkinsonism

Article	Year
Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial. The American journal of medicine, 1997, Volume: 102, Issue:1 Topics: Acetates; Adult; Aged; Amines; Antiparkinson Agents; Cross-Over Studies; Cyclohexanecarboxylic Acids; Double-Blind Method; Electromyography; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Tremor	1997

Article

Year

Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial.

The American journal of medicine, 1997, Volume: 102, Issue:1

Topics: Acetates; Adult; Aged; Amines; Antiparkinson Agents; Cross-Over Studies; Cyclohexanecarboxylic Acids; Double-Blind Method; Electromyography; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Tremor

1997

Other Studies

2 other study(ies) available for phenyl acetate and Atherosclerotic Parkinsonism

Article	Year
Methyl jasmonate abrogates rotenone-induced parkinsonian-like symptoms through inhibition of oxidative stress, release of pro-inflammatory cytokines, and down-regulation of immnopositive cells of NF-κB and α-synuclein expressions in mice. Neurotoxicology, 2019, Volume: 74 Topics: Acetates; alpha-Synuclein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Behavior, Animal; Brain Chemistry; Cyclopentanes; Cytokines; Male; Mice; NF-kappa B; Oxidative Stress; Oxylipins; Parkinson Disease, Secondary; Psychomotor Performance; Rotenone; Uncoupling Agents	2019
In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment. Journal of neurochemistry, 2013, Volume: 127, Issue:3 Topics: Acetates; Algorithms; Animals; Antiparkinson Agents; Blood Glucose; Brain Chemistry; Energy Metabolism; Glutamates; Hand Strength; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neostriatum; Oxidation-Reduction; Parkinson Disease, Secondary; Psychomotor Performance; Radiopharmaceuticals	2013

Article

Year

Methyl jasmonate abrogates rotenone-induced parkinsonian-like symptoms through inhibition of oxidative stress, release of pro-inflammatory cytokines, and down-regulation of immnopositive cells of NF-κB and α-synuclein expressions in mice.

Neurotoxicology, 2019, Volume: 74

Topics: Acetates; alpha-Synuclein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Behavior, Animal; Brain Chemistry; Cyclopentanes; Cytokines; Male; Mice; NF-kappa B; Oxidative Stress; Oxylipins; Parkinson Disease, Secondary; Psychomotor Performance; Rotenone; Uncoupling Agents

2019

In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.

Journal of neurochemistry, 2013, Volume: 127, Issue:3

Topics: Acetates; Algorithms; Animals; Antiparkinson Agents; Blood Glucose; Brain Chemistry; Energy Metabolism; Glutamates; Hand Strength; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neostriatum; Oxidation-Reduction; Parkinson Disease, Secondary; Psychomotor Performance; Radiopharmaceuticals

2013